08.01.2013 Views

Topical treatments for fungal infections of the skin and nails of the foot.

Topical treatments for fungal infections of the skin and nails of the foot.

Topical treatments for fungal infections of the skin and nails of the foot.

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

(95% CI 0.77 to 2.16; Analysis 5.2).<br />

Oxiconazole + fluctic versus oxiconazole<br />

A trial <strong>of</strong> 1% oxiconazole + fluctic used <strong>for</strong> 4 weeks versus 1%<br />

oxiconazole used <strong>for</strong> 4 weeks (n = 201, Elewski 1996) produced<br />

a statistically significant relative reduction in treatment failure <strong>of</strong><br />

47% (RR 0.53, 95% CI 0.33 to 0.87; Analysis 5.2), favouring<br />

oxiconazole + fluctic.<br />

Oxiconazole once per day versus oxiconazole twice per day<br />

Ellis 1989 evaluated oxiconazole once per day compared with oxiconazole<br />

twice per day (n = 110) but found no statistically significant<br />

difference in <strong>the</strong> treatment failure rates (RR 1.23, 95% CI<br />

0.61 to 2.46; Analysis 5.2).<br />

Long-term outcome (12 weeks+)<br />

Clotrimazole four weeks versus clotrimazole one week<br />

In a trial comparing 4 weeks <strong>of</strong> 1% clotrimazole with 1 week <strong>of</strong><br />

1% clotrimazole Bergstresser 1993 found a statistically significant<br />

relative reduction in treatment failure <strong>of</strong> 53% favouring <strong>the</strong> longer<br />

<strong>Topical</strong> <strong>treatments</strong> <strong>for</strong> <strong>fungal</strong> <strong>infections</strong> <strong>of</strong> <strong>the</strong> <strong>skin</strong> <strong>and</strong> <strong>nails</strong> <strong>of</strong> <strong>the</strong> <strong>foot</strong>. (Review)<br />

Copyright © 2009 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.<br />

treatment time (RR at 12 weeks 0.47, 95% CI 0.28 to 0.78;<br />

Analysis 5.4).<br />

Allylamines one to two weeks versus azoles one to two weeks<br />

Short-term outcome (two weeks)<br />

Ten trials (n = 1519, Ablon 1996; Bojanovsky 1985; Evans 1993a;<br />

Evans 1993b; Haas 1985; Leenutaphong 1999; Sanchez 1994<br />

Schopf 1999; Smith 1990b; Smith 1992) comparing 1% allylamines<br />

(naftifine, terbinafine) with 1% azoles (bifonazole, clotrimazole,<br />

oxiconazole) used <strong>for</strong> 1 to 2 weeks showed a small, not<br />

statistically significant, difference in favour <strong>of</strong> allylamines; RR <strong>of</strong><br />

treatment failure at 2 weeks 0.86 (95% CI 0.70 to 1.06; Analysis<br />

6.1). There was considerable variation in <strong>the</strong> results <strong>of</strong> <strong>the</strong> individual<br />

trials (I 2 = 60%).<br />

A L’Abbé plot <strong>of</strong> <strong>the</strong> outcomes at two weeks (Figure 3) demonstrates<br />

that <strong>the</strong> allylamines generally had similar treatment failure<br />

rates to <strong>the</strong> azoles, with a wide variation in failure rates.<br />

13

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!